FARN — Faron Pharmaceuticals Oy Share News
0.000.00%
Last trade - 00:00Faron Pharma. Oy - Results of Oversubscribed Placing
Brief: Faron Pharma Announces EUR 10 Million Private Placement
Faron Pharma. Oy - Proposed Issue and Placing
RCS - Faron Pharma. Oy - Final Patient Identified for BEXMAB Phase II Study
RCS - Faron Pharma. Oy - Faron presents BEXMAB data at ASH Annual Meeting
Brief: Faron Pharmaceuticals Says MHRA Awarded Bexmarilimab An Innovation Passport
RCS - Faron Pharma. Oy - Interactions with UK Regulatory Authorities
RCS - Faron Pharma. Oy - Targeting Soluble Clever-1 for Autoimmune Diseases
RCS - Faron Pharma. Oy - Faron announces Capital Markets Day
Faron Pharma. Oy - Grant of options
Brief: Faron Pharmaceuticals H1 Operating Loss Narrows To EUR 11.3 Mln
Faron Pharma. Oy - Faron 2024 Half-Year Financial Results
Faron Pharma. Oy - FDA Grants Fast Track Designation for Bexmarilimab
Brief: Faron Pharmaceuticals Gets FDA Fast Track Designation For Bexmarilimab
Faron Pharma. Oy - Notice of Half-Year Financial Results
RCS - Faron Pharma. Oy - Traumakine Research Collaboration and DoD Grant
Brief: Faron Pharmaceuticals Oy Appoints Yrjö Wichmann As Permanent CFO
Faron Pharma. Oy - Appointment of Chief Financial Officer
Faron Pharma. Oy - Grant of options